X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS NATCO PHARMA DR. DATSONS LABS/
NATCO PHARMA
 
P/E (TTM) x -10.9 13.2 - View Chart
P/BV x 0.2 3.8 4.3% View Chart
Dividend Yield % 0.0 1.2 -  

Financials

 DR. DATSONS LABS   NATCO PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
NATCO PHARMA
Mar-18
DR. DATSONS LABS/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1261,080 11.6%   
Low Rs31671 4.6%   
Sales per share (Unadj.) Rs133.0592.1 22.5%  
Earnings per share (Unadj.) Rs0.2188.4 0.1%  
Cash flow per share (Unadj.) Rs6.6206.3 3.2%  
Dividends per share (Unadj.) Rs08.25 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs128.8833.6 15.4%  
Shares outstanding (eoy) m31.6636.90 85.8%   
Bonus/Rights/Conversions FCCBIS-  
Price / Sales ratio x0.61.5 39.8%   
Avg P/E ratio x516.14.6 11,104.7%  
P/CF ratio (eoy) x11.84.2 279.1%  
Price / Book Value ratio x0.61.1 57.8%  
Dividend payout %04.4 0.0%   
Avg Mkt Cap Rs m2,47732,311 7.7%   
No. of employees `000NA4.8 0.0%   
Total wages/salary Rs m563,256 1.7%   
Avg. sales/employee Rs ThNM4,522.5-  
Avg. wages/employee Rs ThNM674.0-  
Avg. net profit/employee Rs ThNM1,439.0-  
INCOME DATA
Net Sales Rs m4,21121,848 19.3%  
Other income Rs m79404 19.5%   
Total revenues Rs m4,28922,252 19.3%   
Gross profit Rs m5699,284 6.1%  
Depreciation Rs m204662 30.9%   
Interest Rs m430154 279.4%   
Profit before tax Rs m138,872 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,920 0.3%   
Profit after tax Rs m56,952 0.1%  
Gross profit margin %13.542.5 31.8%  
Effective tax rate %48.021.6 221.9%   
Net profit margin %0.131.8 0.4%  
BALANCE SHEET DATA
Current assets Rs m6,85221,307 32.2%   
Current liabilities Rs m6,7115,920 113.4%   
Net working cap to sales %3.370.4 4.8%  
Current ratio x1.03.6 28.4%  
Inventory Days Days16173 219.6%  
Debtors Days Days318107 299.0%  
Net fixed assets Rs m3,67314,986 24.5%   
Share capital Rs m317369 85.8%   
"Free" reserves Rs m3,76130,353 12.4%   
Net worth Rs m4,07830,760 13.3%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63337,151 34.0%  
Interest coverage x1.058.6 1.8%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.30.6 56.7%   
Return on assets %3.419.1 18.0%  
Return on equity %0.122.6 0.5%  
Return on capital %7.729.3 26.2%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96410,322 9.3%   
Fx outflow Rs m6072,978 20.4%   
Net fx Rs m3577,343 4.9%   
CASH FLOW
From Operations Rs m1,3454,636 29.0%  
From Investments Rs m-2,256-11,155 20.2%  
From Financial Activity Rs m-1,2006,509 -18.4%  
Net Cashflow Rs m-2,111-18 11,726.1%  

Share Holding

Indian Promoters % 4.5 52.0 8.7%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.0 7.8 -  
FIIs % 1.4 16.6 8.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 26.0 361.9%  
Shareholders   20,807 25,395 81.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ALKEM LABORATORIES  STRIDES PHARMA SCIENCE  FDC LTD.  TORRENT PHARMA  DISHMAN PHARMA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Flat; Bharti Airtel & Yes Bank Top Gainers(12:30 pm)

Share markets in India are presently trading on a flat note. Sectoral indices are trading mixed with stocks in the oil & gas sector.

Related Views on News

NATCO PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 115.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 115.2% YoY). Sales on the other hand came in at Rs 5 bn (up 27.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 93.3% YoY). Sales on the other hand came in at Rs 5 bn (up 21.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

More Views on News

Most Popular

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

Are Foreign Investors Heading Back to the Indian Stock Markets?(Chart Of The Day)

Dec 3, 2018

After months of heavy FII selling, November witnessed a return on foreign money into Indian equities...

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS